MAPK/ERK Signaling in Osteosarcomas, Ewing Sarcomas and Chondrosarcomas: Therapeutic Implications and Future Directions.
about
MicroRNAs and Potential Targets in Osteosarcoma: ReviewNon-contact small animal fluorescence imaging system for simultaneous multi-directional angular-dependent data acquisitionGlucosamine sulfate suppresses the expression of matrix metalloproteinase-3 in osteosarcoma cells in vitro.Targeting protein kinases to reverse multidrug resistance in sarcoma.Deciphering signaling networks in osteosarcoma pathobiology.Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1.Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma.Therapy resistance mechanisms in Ewing's sarcoma family tumors.Decrease in stathmin expression by arsenic trioxide inhibits the proliferation and invasion of osteosarcoma cells via the MAPK signal pathway.p16(INK4A) inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1.Anti-angiogenesis target therapy for advanced osteosarcoma (Review).Akt and Hippo Pathways in Ewing's Sarcoma Tumors and Their Prognostic SignificancePhase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma.Individualized doxorubicin sensitivity testing of undifferentiated soft tissue sarcoma (USTS) in a patient-derived orthotopic xenograft (PDOX) model demonstrates large differences between patients.Novel molecular insights and new therapeutic strategies in osteosarcomaAn analysis of the expression and function of myeloid differentiation factor 88 in human osteosarcoma
P2860
Q26784033-61B1CF04-2949-4456-A9F9-910D08CFBCE8Q30839294-E45A2625-2197-406E-9A17-27E48E6B5D3DQ36113597-848413C8-E755-4DD3-A09F-98DAF1477B24Q36527950-7EA5188D-3066-464D-A579-52C93331C130Q37106930-455B7368-BB1A-4C73-8AE3-F1A00723BB5BQ37269236-8ADACE27-64DE-47C2-8C2F-B17BD2C1A02AQ37740672-08DD81B6-7472-49B4-B76B-22A6449DF305Q38182423-6978B860-1CFE-4681-892F-9940B679857FQ38633687-E4B33946-9A8F-4D4D-A1AE-F6D7E2EDD8C1Q38904937-85FBB220-B11E-4379-9858-2E6B8FE3B660Q39401628-AE2BBD26-D65D-47A9-B9A3-5BF98E4D1BEBQ41364679-915A5B7C-32F4-4E9A-AD2E-09C0D193EC90Q46451484-E463FD29-FA1D-482F-9AFC-616D88BD3966Q48135854-ABB0F9A8-FE8C-4EE1-B7EA-6F784C8CEA05Q57814118-5B39ACE9-F72B-4FC7-94B3-29BF4947A433Q58784160-80C3A684-9370-49B4-BFB7-DCB02A221BEA
P2860
MAPK/ERK Signaling in Osteosarcomas, Ewing Sarcomas and Chondrosarcomas: Therapeutic Implications and Future Directions.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
MAPK/ERK Signaling in Osteosar ...... cations and Future Directions.
@en
MAPK/ERK Signaling in Osteosar ...... cations and Future Directions.
@nl
type
label
MAPK/ERK Signaling in Osteosar ...... cations and Future Directions.
@en
MAPK/ERK Signaling in Osteosar ...... cations and Future Directions.
@nl
prefLabel
MAPK/ERK Signaling in Osteosar ...... cations and Future Directions.
@en
MAPK/ERK Signaling in Osteosar ...... cations and Future Directions.
@nl
P2093
P2860
P356
P1433
P1476
MAPK/ERK Signaling in Osteosar ...... cations and Future Directions.
@en
P2093
Chandhanarat Chandhanayingyong
Francis Youngin Lee
J Robert Staples
Yuhree Kim
P2860
P304
P356
10.1155/2012/404810
P577
2012-04-12T00:00:00Z